Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam prophylaxis for prevention of tramadol-associated seizures
IRCT20180608040013N2Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of midazolam in seizure (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Seizures, Number of seizures and 2 more. Started May 2020; status: completed.
02
Drugs
midazolam
03
Conditions
seizure
Beyond the preview
Go deeper on IRCT20180608040013N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180608040013N2.